Nordic Nanovector ASA - Special Call Transcript
Okay. So we're going to start, sharp 9:30. Thank you very much, everyone, for being here. Thank you as well for those that are listening through the webcast. It's a real pleasure for me to be here and take you through our R&D Day. It's been almost 2 years since we haven't done one of these days. So I hope that you will share the excitement of the news that we're going to be sharing with you, some of which, of course, have just been shared earlier this morning.
So we're going to be making plenty of forward-looking statements, so please read carefully the documentation if you're planning on making an investment in the company.
What is Nordic Nanovector, again, for those that maybe are less familiar? So why Nordic Nanovector is an attractive opportunity? We have Betalutin, which is a fully owned asset that is being developed for 2 very large indications. Those 2 indications combined are worth about $5 billion. Very importantly, we have now, with one single administration, data that shows that Betalutin has very significant effect in a trial
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
